One of the major goals of iPSCs research is for disease modeling and novel therapeutic (clinical) applications. Insertion of any genetic materials into the newly generated iPSCs other than iPSC factors is a grave concern for accurate disease modeling. Protein-based iPSCs technology is the only solution to this problem. This method completely eliminates genome manipulation associated with vector-based iPSC factors. ABM provides both human and mouse recombinant iPSC proteins in either crude cell lysate or purified protein format. All recombinant proteins have been expressed in human 293 cells and functionally tested. For maximal success transfecting our iPSC proteins it is recommended you use our Proteinfectin.